Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT07182903
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of relapsing remittion, primary progressive or secondary progressive MS
* Age: 18-60 years
* Ability to perform the foot-tapping task
* Ability to walk at least 20 meters (with or without walking aid)
Exclusion Criteria:
* Dimethyl fumarate, fingolimod or alemtuzumab treatment, since these medications have a strong influence on the immune system As a result of these treatments, there are few to no immune cells circulating in the blood, meaning we cannot find our population of interest in the blood.
* Change in medication 6 weeks before the start of the study (including medication not related to MS) - MS relapse within 6 weeks of the start of the study
* Had an infection in the last month - Received a vaccination in the last 14 days - Pregnant or pregnancy in the last 6 months
* Having a psychiatric disorder
* Having a neurological disorder other than MS
* Having cognitive or communicative problems that makes it hard to follow instructions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT07182903
Study Brief:
Protocol Section:
NCT07182903